1 / 30

OSTEOPENIA OF PREMATURITY

OSTEOPENIA OF PREMATURITY. ICN – JUNE / 2004 Vilma I. Dobbs, MD . CALCIUM (Ca). The most abundant mineral in the body 99% in skeleton From this 1/3 is readily interchangeable with ECF Serum Ca exist in 3 separated fractions:

hayes
Download Presentation

OSTEOPENIA OF PREMATURITY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. OSTEOPENIA OF PREMATURITY ICN – JUNE / 2004 Vilma I. Dobbs, MD

  2. CALCIUM (Ca) • The most abundant mineral in the body • 99% in skeleton • From this 1/3 is readily interchangeable with ECF • Serum Ca exist in 3 separated fractions: • Protein-bound: 40% , > albumin • Complexed with anions: 10% , citrate, P, HCO3, & sulfate • Free ionized: 50%, physiologically active

  3. Ca- Regulation of serum concentration • PTH • Calcitonine (CT) • Vitamin D

  4. Ca – Regulation of serum concentration • PTH • PTH ↑ => If serum Ionized Ca ↓ • In Bone: ↑ Ca resorption (release of Ca & P into Extracelullar fluid & circulation • In Kidney: ↑ Ca urinary excretion • In GI: Indirectly through Vit-D ↑ GI absorption of Ca • Net effect of PTH is ↑ Ca concentration

  5. Ca- Regulation of serum concentration • CALCITONINE • CT ↑ If => ↑ Ca in serum • In Bone: bone resorption • In Kidney: @↑↑ of calcitonine ↑ urinary excretion of Ca & P • Net effect of CT is ↓ Ca & P

  6. Ca- Regulation of serum concentration • VITAMIN - D • PO / GI absorbed • Skin / UV light • Liver => 1stOH => 25 OH – Vit-D • Kidney => 2nd OH => 1,25 OH –Vit-D • Active form • In GI: small intestine => active absorption of Ca • In Bone w PTH => Bone resorption • Net effect of Vit-D (1,25OH) is ↑ Ca

  7. Ca GI Transport • GI tract is the 1ry site involved in the long term regulation of Ca balance. • Ca absorption: • Passive : • all small intestine • Related to intraluminal Ca concentration • Apparently no regulatory process • Active : • 1ry in duodenum • Strongly influenced by Vit-D • 1,25 OH Vit-D ↑ absorption of Ca

  8. Ca GI Transport • ↑ Alk Ph. when exposed to 1,25 OH-Vit-D • In PT baby if ↑ Ca intake => ↑ GI absorp. of Ca • Human milk & formula supplemented with Vit-D => ↑↑ Ca absorption • Intestinal maturation is accelerated by preterm delivery ↑

  9. Ca GI Transport • CHO & Glucose polymers ↑Ca / GI absorption. (unclear mech.). Independent of Vit-D • Osmotic forces that ↑ GI absorption of water also ↑ passive absorption of Ca.

  10. Ca GI Transport • If dietary restriction of Ca or P => ↑ prod. of 1,25 OH-Vit-D => ↑ active GI Ca absorption. • Fat malabsorption • PT baby w ↓ bile salts (micelle-phase) =>↓ fat absorption => unabsorbed free fatty acids<=> interact with ionic Ca => Insoluble Soaps => Ø Ca absorption

  11. OSTEOPENIA OF PREMATURITY (OOP) • DEFINITION • Is a Metabolic Bone Disease of PT infants, in which decreased bone mineral content occurs mainly as a result of lack of adequate Ca & P intake in extra uterine life.

  12. OOP • The bone mineral content of a PT infant is significantly decreased relative to the expected level of mineralization for a fetus or infant of comparable size or gestational age. It is a common problem in babies of <1000gr who have low intakes of Ca & P.

  13. OOP • The accretion of Ca & P ↑ exponentially in the fetus during 3er trimester, ≈ 80% present at term. • To achieve similar rates of accretion for normal growth & bone mineralization, small PT require higher intakes of Ca & P x Kg than do Term infants.

  14. OOP • Fetus of 28 – 38 wks -will ↑ Wt. x 3 -will ↑Ca content x 4 => rate: 120-150 mg/kg/d -will ↑P content => rate: 75- 85 mg/kg/d • While Mother will: -↑ PTH -↑ 1,25 OH-Vit-D -↑ Ca absorption -↑ Ca mobilization

  15. OOP – RISK FACTORS • < 34 Wks • < 1500 gr • Delayed establishment of full enteral feedings • Complicated neonatal course • Prolonged parenteral nutrition

  16. OOP – RISK FACTORS • Enteral feedings / low mineral content/bioavail. • Unsupplemented human milk • Soy-based infant formulas • Standard term milk-based formulas • Chronic use of meds. That ↑ mineral excretion • Diuretics, steroids, NaHCO3 • Cholestatic jaundice

  17. OOP- CLINICAL FINDINGS • From mild demineralization to overt rickets & non-traumatic Fxs., or rachitic RD • Clinically silent • Dx usually @ 2 - 4 mo • Craniotabes, frontal bossing • Thickening of wrist & ankles, rachitic rosary • Impaired rate of linear growth • Enamel hypoplasia

  18. OOP - DIAGNOSIS ROUTINE TESTS • ↑ serum Alk. Ph. > 400 IU • ↓ serum P < 3.5 mg/dl • Normal Ca • Abnormal X-ray of wrist or knee • ↓ bone density • Cupping & irregularity of metaphyses & Fxs. • X-ray evidence is often present by the end of 1st mo

  19. OOP – GENERAL NUTRITION LABS 500 - 1500 grs • BMP Q day until stable on TPN • BMP Wed & Sat until > 1500 gr unless stable • Ca & P Q wed & Sat while in TPN until stable • T & D Bili Q Wed while in TPN • D/Bili is the 1st↑ in TPN cholestasis • If D/Bili ↑ => F/U LFT’s w GGT Q other Wk • F/U D/Bili (even TPN off) until <1.5-2 mg/dl

  20. Contin….OOP – GENERAL NUTRITION LABS • Alkaline phosphatase Q other wed., started the 2dn wk of life. • Marker ↑ before changes noted on x-ray • Abnormal if > 400 or 500 U/L • F/U until < 300 or 350 U/L on PT formula • Spun Hct & retic. Q wed • Triglyceride: after 1st 24 hrs on lipids, then daily after 1.5 gr/kg/d until stable on 3mg/kg/d

  21. OOP - DIAGNOSIS • SUPLEMENTARY TESTS • Normal or ↓ 25, oh-Vit-D • ↑ 1,25, OH –Vit-D • ↑ or Normal PTH • Bone density • Single photon absormetry (SPA) • Dual energy X-ray asorptiometry (DXA) • Bone mineral content (BMC) • Bone mineral density (BMD)

  22. PREVENTIVE NUTRITION • Theoretically => Feeds w ↑↑ Ca & P (Equivalent to utero accretion rates) • Parenteral nutrition • Partial Parenteral / Enteral nutrition • Enteral nutrition

  23. PREVENTIVE NUTRITION • PARENTERAL NUTRITION • 1ST few days or wks • Amount of Ca & P given is limited 2ry to precipitation

  24. PREVENTIVE NUTRITION FACTORS / ↑ SOLUBILITY • Ca : salt form => ↑ Ca gluconate • P : order of mixing => ↑ 1st P =>Ca • AA : & composition => ↑cysteine • Dextrose : ↑ concentration • Temp : ↑ temp. • pH : ↓ pH

  25. PREVENTIVE NUTRITION THE GOAL IS : • Ca : P ratio => 1.7 : 1 • Trophamine 0.8 gr / dL • Ca gluconate • K phosphate • Advancing to or continuing feedings of fortified human milk or preterm formula

  26. PREVENTIVE NUTRITION • A wide range of Ca:P ratios have been used in Parenteral Nutrition solutions. • Studies using ratios of 1.3 : 1 to 1.7:1 have reported high mineral retention and minimal problems with tolerance

  27. PREVENTIVE NUTRITION • PRACTICAL WAY TO MIX Ca & P IN TPN SOLUTIONS • Trophamine 3 gr with Cysteine 40 mg • Ca 4 – 5 mEq for every 100 ml of TPN • P 1.5 – 2.5 mM for every 100 ml of TPN

  28. PREVENTIVE NUTRITION • Conversion to gr. • Ca mEq to gr = x 20 • P mM to gr = x 30

  29. PREVENTIVE NUTRITION(the numbers are rounded)

  30. VITAMIN - D • Deficiency is very rare in PT in USA • It is implicated in OOP • The main cause of OOP is deficiency of Ca & P • Recommended intake : 125 – 333 IU/100 kcal/d • Human milk fortified & special Pt formulas will supply 200 – 400 IU/d

More Related